Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Ter Arkh ; 91(2): 25-31, 2019 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-31094168

RESUMEN

AIM: To evaluate the effectiveness of enteroprotector Rebamipide in the treatment of enteropathy with impaired membrane digestion (EIMD). MATERIALS AND METHODS: We examined 102 patients aged 18 to 50 years (41 men and 61 women) with clinical signs of irritable bowel syndrome (n=65), functional diarrhea (n=33), and functional constipation (n=4) according to Rome IV criteria (2016). The activities of glucoamylase (GA), maltase, sucrase and lactase were determined by Dahlquist-Trinder method in duodenal biopsies obtained during esophagogastroduodenoscopy. The control group consisted of 20 healthy people aged 23-47. They showed following average enzyme activity: lactase - 42±13 ng glucose on 1 mg of tissue per minute, GA - 509±176, maltase - 1735±446, sucrase - 136±35 ng glucose on 1 mg of tissue per minute. These numbers were taken as the norm. RESULTS: The activity of the disaccharidases was reduced in 89.2% out of 102 patients, and they were diagnosed with EIMD. Thirteen patients with EIMD were recommended to maintain the FODMAP diet and take enteroprotector Rebamipide 100 mg 3 times a day for 12 weeks. After 3 months 11 patients reported decreased or no flatulence, abdominal pain, stool disorder; 2 patients reported no change. The activity of GA increased to an average of 149±82 (by 78%, p=0.016), maltase - to 864±472 (by 131%, p=0.0019), sucrase - 63±35 (by 95%, p=0.0041) and lactase - 10±8 ng glucose on 1 mg of tissue per minute. The activity of lactase did not change. CONCLUSION: We discovered a previously unknown phenomenon of the disaccharidases activity increase in duodenal mucosa and improved carbohydrates tolerance in the patients with EIMD taking Rebamipide in the dose 300 mg/day for 12 weeks.


Asunto(s)
Alanina/análogos & derivados , Disacaridasas/efectos de los fármacos , Síndrome del Colon Irritable , Síndromes de Malabsorción , Quinolonas/farmacología , Adolescente , Adulto , Alanina/administración & dosificación , Alanina/farmacología , Estudios de Casos y Controles , Estreñimiento , Diarrea , Disacaridasas/metabolismo , Femenino , Humanos , Mucosa Intestinal , Síndrome del Colon Irritable/complicaciones , Síndrome del Colon Irritable/enzimología , Síndromes de Malabsorción/enzimología , Masculino , Persona de Mediana Edad , Proyectos Piloto , Quinolonas/administración & dosificación , Sacarasa , Adulto Joven
2.
Nutr Hosp ; 23(4): 326-31, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18604318

RESUMEN

Non-steroidal anti-inflammatory drugs (NSAIDs) are known to cause gastrointestinal damage. New anti-inflammatory drugs have been developed in an attempt to improve their gastrointestinal side effect profile which however failed to do so. Therefore, the objective of the present study was to compare the effect of three different NSAIDs, aspirin, nimesulide and celecoxib on the intestinal brush border membrane (BBM) marker enzymes and correlate these alterations to the histoarchitecture of the intestine using electron microscopic study. Female Wistar rats were divided into four different groups viz: Group I (Control), Group II (aspirin treated), Group III (nimesulide treated) and Group IV (celecoxib treated). The Group II, III and IV received the corresponding drugs dissolved in water orally at a dose of 40 mg/kg body weight, while the control received the vehicle only. After 28 days, all the treatment groups demonstrated significant alterations in the activities of intestinal disaccharide hydrolases and alkaline phosphatase in both the crude homogenates and BBM preparations as well. The histopathological observations also showed considerable changes in the intestinal mucosa. It was suggested that NSAIDs like aspirin, nimesulide and celecoxib pose intestinal side effects due to initial changes in the enzymatic composition of the intestinal apical membranes. It was further concluded that newly discovered NSAIDs such as celecoxib has better safety profiles but studies are still required to comment decisively on the suitability of various NSAIDs depending upon their cyclooxygenase enzyme specificity.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Aspirina/farmacología , Disacaridasas/efectos de los fármacos , Intestinos/efectos de los fármacos , Intestinos/ultraestructura , Pirazoles/farmacología , Sulfonamidas/farmacología , Animales , Celecoxib , Femenino , Microscopía Electrónica de Rastreo , Microvellosidades/efectos de los fármacos , Ratas , Ratas Wistar
3.
Insect Biochem Mol Biol ; 37(12): 1348-58, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17967353

RESUMEN

Mulberry leaves (Morus spp.) exude latex rich in sugar-mimic alkaloids, 1,4-dideoxy-1,4-imino-d-arabinitol (d-AB1) and 1-deoxynojirimycin (DNJ), as a defense against herbivorous insects. Sugar-mimic alkaloids are inhibitors of sugar-metabolizing enzymes, and are toxic to the Eri silkworm, Samia ricini, a generalist herbivore, but not at all to the domesticated silkworm, Bombyx mori, a mulberry specialist. To address the phenomena, we fed both larvae diets containing different sugar sources (sucrose, glucose or none) with or without sugar-mimic alkaloids from mulberry latex. In S. ricini, addition of sugar-mimic alkaloids to the sucrose (the major sugar in mulberry leaves) diet reduced both growth and the absorption ratio of sugar, but it reduced neither in B. mori. The midgut soluble sucrase activity of S. ricini was low and inhibited by very low concentrations of sugar-mimic alkaloids (IC(50)=0.9-8.2microM), but that of B. mori was high and not inhibited even by very high concentrations (IC(50)>1000microM) of sugar-mimic alkaloids. In S. ricini, the addition of sugar-mimic alkaloids to the glucose diet still had considerable negative effects on growth, although it did not reduce the absorption ratio of glucose. The hemolymph of S. ricini fed sugar-mimic alkaloids contained sugar-mimic alkaloids. The trehalose concentration in the hemolymph increased significantly in S. ricini fed sugar-mimic alkaloids, but not in B. mori. The trehalase activities of S. ricini were lower and inhibited by lower concentrations of sugar-mimic alkaloids than those of B. mori. These results suggest that sugar-mimic alkaloids in mulberry latex exert toxicity to S. ricini larvae first by inhibiting midgut sucrase and digestion of sucrose, and secondly, after being absorbed into hemolymph, by inhibiting trehalase and utilization of trehalose, the major blood sugar. Further, our results reveal that B. mori larvae evolved enzymatic adaptation to mulberry defense by developing sucrase and trehalase that are insensitive to sugar-mimic alkaloids.


Asunto(s)
Alcaloides/farmacología , Bombyx/metabolismo , Metabolismo de los Hidratos de Carbono/efectos de los fármacos , Disacaridasas/efectos de los fármacos , Morus/química , Adaptación Fisiológica , Alcaloides/aislamiento & purificación , Animales , Evolución Biológica , Bombyx/efectos de los fármacos , Bombyx/crecimiento & desarrollo , Hemolinfa/enzimología , Larva/efectos de los fármacos , Larva/crecimiento & desarrollo , Larva/metabolismo , Látex/química , Mariposas Nocturnas/efectos de los fármacos , Trehalasa/metabolismo , Trehalosa/metabolismo
4.
J Anim Sci ; 85(2): 477-85, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17040948

RESUMEN

The aim of this study was to obtain information that could help to ease the weaning transition in commercial pig production. Before weaning, phytohemagglutinin (PHA) in the form of a crude preparation of red kidney bean lectin was fed by gavage to 24 crossbred [(Swedish Landrace x Yorkshire) x Hampshire] piglets, whereas 24 control piglets were fed alpha-lactalbumin by gavage, to study the effect on growth, occurrence of postweaning diarrhea, feeding behavior, and some anatomical and physiological traits of the gastrointestinal tract. Within the litter, piglets were randomly assigned to PHA treatment or control and remained in the same pen from the beginning (PHA exposure at 7 d before weaning) until the end of the experiment (14 d post-weaning). Weaning took place at the age of 31 to 34 d. Pigs treated with PHA grew faster (P = 0.013) during the first week postweaning and tended to have lower total diarrhea scores (P = 0.10) than did control pigs. On d 5 after weaning, piglets treated with PHA spent more time eating (P = 0.028) than control pigs. No immunostimulating effect of PHA, measured by plasma immunoglobulin G, could be detected. An increase in the intestinal barrier properties before weaning, as a response to PHA treatment, was demonstrated in intestinal absorption studies using Na-fluorescein and BSA as gavage-fed markers. Less uptake (measured as plasma concentrations) of the marker molecule Na-fluorescein occurred during a 24-h study period, and numerically lower levels of BSA were observed compared with studies in control pigs of the same age. A total of 12 pigs (6 control, 6 PHA-treated) were euthanized on the day of weaning for analyses of gastrointestinal properties. The PHA-treated pigs tended to have a longer total small intestinal length (P = 0.063) than that of the control pigs. The enzyme profile of the jejunal epithelium responded to PHA exposure with a decrease in lactase activity and an increase in maltase and sucrase activities, which is similar to changes normally observed after weaning. No differences were found in the size of the pancreas or in its contents of trypsin and amylase. In conclusion, exposing piglets to crude, red kidney bean lectin for 3 d during the week before weaning led to changes in performance and small intestinal functional properties that would be expected to contribute to a more successful weaning.


Asunto(s)
Conducta Alimentaria/efectos de los fármacos , Absorción Intestinal/efectos de los fármacos , Intestino Delgado/efectos de los fármacos , Fitohemaglutininas/farmacología , Porcinos/fisiología , Aumento de Peso/efectos de los fármacos , Animales , Proteínas Sanguíneas/análisis , Proteínas Sanguíneas/efectos de los fármacos , Diarrea/microbiología , Diarrea/veterinaria , Disacaridasas/análisis , Disacaridasas/efectos de los fármacos , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/veterinaria , Fluoresceína/administración & dosificación , Fluoresceína/análisis , Fluoresceína/metabolismo , Inmunoglobulina G/sangre , Inmunoglobulina G/efectos de los fármacos , Intestino Delgado/enzimología , Intestino Delgado/crecimiento & desarrollo , Yeyuno/efectos de los fármacos , Yeyuno/enzimología , Lactalbúmina/administración & dosificación , Lactalbúmina/farmacología , Páncreas/química , Páncreas/efectos de los fármacos , Páncreas/enzimología , Distribución Aleatoria , Porcinos/crecimiento & desarrollo , Enfermedades de los Porcinos/microbiología , Enfermedades de los Porcinos/fisiopatología , Destete
5.
Plant Foods Hum Nutr ; 60(2): 87-91, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16021836

RESUMEN

To elucidate the effect of feeding fenugreek seed mucilage and spent turmeric (10%) on disaccharidases activities, the specific activities of intestinal and renal disaccharidases viz., sucrase, maltase and lactase were measured in streptozotocin induced diabetic rats. Specific activities of intestinal disaccharidases were increased significantly during diabetes and amelioration of these activities during diabetes was clearly visible by supplementing fenugreek seed mucilage and spent turmeric in the diet. However during diabetes renal disaccharidases activities were significantly lower than those in the control rats. Fenugreek seed mucilage and spent turmeric supplementations were beneficial in alleviating the reduction in maltase activity during diabetes, however not much change in the activities of sucrase and lactase was observed upon feeding. This positive influence of feeding fenugreek seed mucilage and spent turmeric on intestinal and renal disaccharidases clearly indicates their beneficial role in the management of diabetes.


Asunto(s)
Curcuma/química , Diabetes Mellitus Experimental/enzimología , Disacaridasas/metabolismo , Intestinos/enzimología , Riñón/enzimología , Trigonella/química , Animales , Glucemia , Disacaridasas/efectos de los fármacos , Lactasa/metabolismo , Masculino , Distribución Aleatoria , Ratas , Ratas Wistar , Sacarasa/metabolismo
6.
Nahrung ; 46(5): 345-8, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12428451

RESUMEN

To elucidate the effect of feeding of butyric acid on disaccharidase activities, the specific activities of the disaccharidases were measured in the intestinal mucosa and kidney cortex of control and diabetic rats. Diabetes was induced in rats using streptozotocin. Rats were fed with basal diet containing wheat bran (5%) as a source of insoluble dietary fiber and guar gum (2.5%) as a source of soluble dietary fiber. The experimental group received butyric acid at 250, 500 and 750 mg/kg body weight/day. Increased activities of intestinal maltase, sucrase and lactase in diabetic rats were significantly reduced in fiber-fed diabetic group. Supplementation of butyric acid at 500 mg/kg body weight/day showed a further decrease in their activities. The activity of disaccharidases in renal tissue was decreased in diabetic rats and was significantly improved in fiber-fed diabetic group. Butyric acid feeding at 500 mg/kg body weight/day showed further improvement in their activities.


Asunto(s)
Ácido Butírico/farmacología , Diabetes Mellitus Experimental/enzimología , Disacaridasas/metabolismo , Animales , Glucemia/análisis , Glucemia/efectos de los fármacos , Ácido Butírico/administración & dosificación , Fibras de la Dieta/administración & dosificación , Disacaridasas/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Mucosa Intestinal/enzimología , Intestino Delgado/enzimología , Corteza Renal/enzimología , Masculino , Distribución Aleatoria , Ratas , Ratas Wistar , Almidón/administración & dosificación
7.
J Vet Med A Physiol Pathol Clin Med ; 49(2): 81-6, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11958471

RESUMEN

The purpose of this study was to test whether dietary spray-dried porcine plasma (SDPP) in early-weaned piglets prevents small intestinal villus atrophy by trophic or protective activity. Fifty-four weaned, 18-day-old piglets were used to determine the effect of dietary SDPP on small intestinal villus length, crypt depth, enterocyt mitotic activity and brush border enzyme activities during the first week after weaning. The piglets were offered a diet containing either 8% SDPP or 8% casein. At 2 and 7 days after weaning, piglets were anaesthetized to provide samples of the small intestinal wall and killed immediately afterwards. There were no differences in daily gain and daily feed intake between the two dietary treatments. At day 2 after weaning, all piglets showed a marked reduction in villus height when compared with baseline values. In all piglets, small intestinal enterocyte mitotic activity had decreased by day 2 and was increased again on day 7. There were no significant effects of dietary SDPP on small intestinal villus length, crypt depth and enterocyt mitotic activity. This indicates that SDPP has no trophic effect on the small intestinal mucosa and that it does not protect against the damaging effect on the small intestinal villi that is associated with the process of weaning. There was no effect of SDPP on lactase-, sucrase- or maltase-specific activities that are a measure of the digestive function of the small intestine. It can be concluded that SDPP versus casein has no effect on small intestinal morphology and disaccharidase activities in early weaned piglets kept under low infection pressure.


Asunto(s)
Dieta/veterinaria , Proteínas en la Dieta/farmacología , Disacaridasas/efectos de los fármacos , Intestino Delgado/efectos de los fármacos , Porcinos/metabolismo , Alimentación Animal , Animales , Animales Recién Nacidos , Disacaridasas/metabolismo , Femenino , Intestino Delgado/enzimología , Masculino , Microvellosidades/efectos de los fármacos , Microvellosidades/enzimología , Porcinos/anatomía & histología , Destete
8.
Gut ; 49(2): 182-9, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11454792

RESUMEN

BACKGROUND: Erythropoietin (Epo) receptors are present on enterocytes of fetal and neonatal small bowel but the role of Epo in the bowel is not known. AIMS: We tested the following hypotheses: (1) enterally dosed Epo is absorbed from the intestines of neonatal rats, (2) Epo acts as a trophic factor in developing small bowel, and (3) the trophic effects of Epo are dependent on the route of administration. METHODS: The dose dependent effects of enterally dosed recombinant human erythropoietin (rEpo 0--1000 U/kg/day) were studied in artificially raised rat pups and compared with dam raised controls and dam raised pups given rEpo in rat milk. After one week, reticulocyte counts, haematocrits, and plasma Epo concentrations were measured, and calibrated morphometric measurements of villi were performed. The effects of route of rEpo administration (enteral v parenteral) on erythropoiesis, bowel growth, and disaccharidase activity were studied in nursing pups treated for one and two weeks. RESULTS: Serum Epo concentrations ranged from undetectable (<0.6 mU/ml) to 8.4 mU/ml in control and enterally dosed pups (median 1.8 mU/ml), and from 4.9 to 82.3 mU/ml (median 20.4 mU/ml) in parenterally dosed animals. No increase in haematocrit or reticulocyte count was noted in enterally treated pups compared with controls after up to two weeks of treatment. Small bowel length was greater in rEpo treated pups, and a dose dependent increase in villus surface area which was independent of the route of dosing and associated with increased BrdU uptake was found. CONCLUSIONS: rEpo is not enterally absorbed in an intact and functional form from the intestines of neonatal rat pups. Thus enterally dosed rEpo has no erythropoietic effects. However, rEpo acts as a trophic factor in developing rat small bowel whether given enterally or parenterally.


Asunto(s)
Eritropoyetina/farmacología , Intestinos/efectos de los fármacos , Animales , Animales Recién Nacidos , Bromodesoxiuridina/metabolismo , Disacaridasas/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Eritropoyesis/efectos de los fármacos , Eritropoyetina/administración & dosificación , Eritropoyetina/sangre , Hematócrito , Procesamiento de Imagen Asistido por Computador , Absorción Intestinal/fisiología , Intestinos/crecimiento & desarrollo , Modelos Lineales , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes , Recuento de Reticulocitos
9.
Br J Nutr ; 74(2): 229-37, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7547840

RESUMEN

The effects of oat saponins (a mixture of avenacosides A and B) and dietary fibre (cellulose and guar gum) on the disaccharidase activities in the proximal small intestine of the rat were investigated. The influence of avenacosides A and B on the activity of disaccharidases and alpha-amylase (EC 3.2.1.1) was also studied in vitro. In vivo, oat diets with three avenacoside contents (negligible, normal and twice normal) were used. No significant differences in sucrase (EC 3.2.1.48), maltase (EC 3.2.1.20), trehalase (EC 3.2.1.28) and lactase (EC 3.2.1.21) activities were found between the oat groups after 19 d feeding. The rats that were given cellulose tended to have higher disaccharidase activities compared with the other groups. The avenacosides inhibited the lactase activity significantly in vitro while no or small effects on the other disaccharidases were found. In contrast, the in vitro hydrolysis of starch by alpha-amylase was increased in the presence of saponins, probably due to their detergent effect. Thus, the in vitro studies showed that the avenacosides could influence the enzyme activities. In vivo, these effects are probably minor due to the low avenacoside concentrations found in oats.


Asunto(s)
Avena , Carbohidratos de la Dieta/metabolismo , Fibras de la Dieta/farmacología , Digestión/efectos de los fármacos , Saponinas/farmacología , Animales , Disacaridasas/efectos de los fármacos , Disacaridasas/metabolismo , Mucosa Intestinal/enzimología , Masculino , Ratas , Ratas Sprague-Dawley , alfa-Amilasas/efectos de los fármacos , alfa-Amilasas/metabolismo
10.
J Pediatr Surg ; 30(7): 983-6; discussion 986-7, 1995 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7472958

RESUMEN

Infants with gastroschisis experience delayed intestinal motility and absorption for several weeks after birth. This intestinal dysfunction is believed to occur primarily in the third trimester and to be largely caused by the prolonged exposure of the intestine to amniotic fluid. Previous studies have shown that prenatal steroid administration will enhance mucosal disaccharidase activity and nutrient uptake. The present study evaluates the effects of dexamethasone on intestinal function in a rabbit fetal gastroschisis model. Thirty-four fetuses from 10 New Zealand white rabbits were divided into three groups: (1) gastroschisis group (GSC, n = 10), gastroschisis was created on gestational day (GD) 24 (term = 31 to 33 days); (2) dexamethasone group (GSD, n = 10), after the creation of gastroschisis, a small osmotic pump was placed into the rabbit doe for dexamethasone infusion into the fetal amniotic cavity for 7 days (0.2 microgram/g/d); (3) normal group (NF, n = 10), unoperated littermates from the GSC group. There were no maternal deaths, and fetal survival rate was 85%. The fetal small intestinal disaccharidase enzyme, lactase (UE/g protein), was markedly decreased in GSC fetuses. It was increased 70% in the GSD group but lower than in normal fetuses (GSC = 10.0 +/- 1.6; GSD = 17.3 +/- 1.6 [GSD versus GSC, P < .05]; NF = 48.0 +/- 6.7). Maltase activity in the GSD group was significantly increased (GSC = 7.2 +/- 1.1; GSD = 13.9 +/- 1.8 [GSD versus GSC, P < .05]; NF = 12.2 +/- 1.3).(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Músculos Abdominales/anomalías , Dexametasona/uso terapéutico , Enfermedades Fetales/fisiopatología , Absorción Intestinal/efectos de los fármacos , Intestino Delgado/efectos de los fármacos , Músculos Abdominales/fisiopatología , Amnios , Animales , Dexametasona/administración & dosificación , Disacaridasas/efectos de los fármacos , Modelos Animales de Enfermedad , Femenino , Motilidad Gastrointestinal/efectos de los fármacos , Edad Gestacional , Glucosa/metabolismo , Hernia Ventral/fisiopatología , Bombas de Infusión Implantables , Inyecciones , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/enzimología , Intestino Delgado/enzimología , Lactasa , Embarazo , Conejos , Tasa de Supervivencia , alfa-Glucosidasas/efectos de los fármacos , beta-Galactosidasa/efectos de los fármacos
11.
Strahlenther Onkol ; 170(8): 467-70, 1994 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8085213

RESUMEN

PURPOSE: The aim of this investigation was to determine whether pre- or post-administration of vitamin A will be effective in reducing the radiation-induced alterations in intestinal disaccharidases in rats. MATERIAL AND METHODS: Rats were subjected to fractionated whole-body irradiation (20 x 0.5 Gy). Intestinal lactase activity as well as maltase and sucrase activities were assessed. Vitamin A was administered at daily intraperitoneal dose of 15,000 IU/kg body weight for 7 days prior to radiotherapy and thereafter twice weekly throughout therapy up to 7 days post irradiation. RESULTS: In irradiated rats a marked decrease in intestinal lactase activity to about one-fourth of those in non-irradiated rats was observed. In addition, a significant reduction in maltase and sucrase activities to one half of the control group was observed. The application of vitamin A significantly improved the radiation-induced inhibition of intestinal enzymes. Pretreatment application of vitamin A is more efficient to protect against radiation injury than a posttreatment application. CONCLUSIONS: The usage of vitamin A for modulation of radiation-induced changes in intestinal enzymes provides sufficient protection against treatment side effects induced by large volume radiotherapy.


Asunto(s)
Disacaridasas/efectos de la radiación , Rayos gamma , Intestinos/enzimología , Vitamina A/farmacología , Animales , Disacaridasas/efectos de los fármacos , Inyecciones Intraperitoneales , Intestinos/efectos de los fármacos , Intestinos/efectos de la radiación , Yeyuno/enzimología , Yeyuno/efectos de la radiación , Lactasa , Masculino , Dosis de Radiación , Ratas , Ratas Wistar , Sacarasa/metabolismo , Sacarasa/efectos de la radiación , Vitamina A/administración & dosificación , Irradiación Corporal Total , alfa-Glucosidasas/metabolismo , alfa-Glucosidasas/efectos de la radiación , beta-Galactosidasa/metabolismo , beta-Galactosidasa/efectos de la radiación
12.
J Trop Pediatr ; 40(3): 179-84, 1994 06.
Artículo en Inglés | MEDLINE | ID: mdl-8078118

RESUMEN

This study aims to determine the effect of glucose and glucose polymers (GP) from corn in oral rehydration solutions (ORS) on disaccharidases and morphometric measurements in small intestinal mucosa of rats. ORS containing standard composition of salts as in WHO ORS and 2, 5, or 10 per cent glucose or GP [initial glucose polymers, long chain (> 9 molecules) and short chain (2-9 molecules) glucose polymers] from corn were infused into the duodenum of 72 Sprague-Dawley rats (250-350 g). Six rats were sham operated as controls. The levels of lactase, sucrase, maltase, palatinase, and glucoamylase enzymes were higher in rats infused with ORS-containing glucose or GP than control rats. Villus height, villus width, and crypt height in corresponding segments of duodenum, jejunum, and ileum were not significantly different between rats perfused with ORS containing glucose polymers from corn and those with ORS containing glucose. ORS containing GP from corn have no adverse effects on small intestinal enzymes and morphometric measurements.


Asunto(s)
Fluidoterapia , Glucanos/administración & dosificación , Glucosa/administración & dosificación , Mucosa Intestinal/efectos de los fármacos , Intestino Delgado/efectos de los fármacos , Soluciones para Rehidratación/administración & dosificación , Zea mays , Animales , Disacaridasas/efectos de los fármacos , Mucosa Intestinal/anatomía & histología , Mucosa Intestinal/enzimología , Intestino Delgado/anatomía & histología , Intestino Delgado/enzimología , Lactasa , Masculino , Ratas , Ratas Sprague-Dawley , Sacarasa/efectos de los fármacos , alfa-Glucosidasas/efectos de los fármacos , beta-Galactosidasa/efectos de los fármacos
13.
J Pediatr Surg ; 28(10): 1239-44, 1993 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8263680

RESUMEN

As fetal swallowing is documented in utero, supplementation of the ingested amniotic fluid with nutrients or hormones has been postulated as a potential prenatal treatment for intrauterine growth retardation (IUGR). To study the effect of epidermal growth factor (EGF) on the developing fetal small intestine, 12 pregnant rabbits underwent operation on day 24 of a normal 31-day gestation. Bilateral ovarian end fetuses underwent catheterization of their respective amniotic cavities with attachment to a miniosmotic pump. Study fetuses received recombinant human EGF at approximately 300 micrograms/kg/d for 1 week; controls received carrier solution only at an equivalent rate. On gestational day 31, fetuses were delivered by cesarean section and somatic measurements were recorded. The small intestine was harvested and proximal, middle, and distal regions were analyzed for lactase and maltase enzyme activity. Additionally, the uptake of radiolabeled glucose and proline was measured by a standard everted mucosal sleeve technique for each segment. Results were analyzed by Student's paired t test and reported as mean +/- SEM. Nine fetal pairs survived (75%). Small intestinal (SI) length was increased in EGF fetuses (54.8 +/- 1.9 cm) versus control (50.4 +/- 2.7 cm) (P = .02). Lactase activity, reported as UE/g protein, was significantly increased in the proximal segments in the EGF-infused fetuses; maltase was significantly increased in both the proximal and middle segments (P < .05).(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Disacaridasas/efectos de los fármacos , Factor de Crecimiento Epidérmico/administración & dosificación , Intestino Delgado/efectos de los fármacos , Amnios , Animales , Transporte Biológico/efectos de los fármacos , Disacaridasas/metabolismo , Evaluación Preclínica de Medicamentos , Femenino , Retardo del Crecimiento Fetal/tratamiento farmacológico , Glucosa/metabolismo , Humanos , Bombas de Infusión Implantables , Intestino Delgado/embriología , Intestino Delgado/metabolismo , Embarazo , Prolina/efectos de los fármacos , Prolina/metabolismo , Conejos , Proteínas Recombinantes/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...